Prognostic Utility of Systemic Immune-Inflammation Index After Resection of Extrahepatic Cholangiocarcinoma: Results from the U.S. Extrahepatic Biliary Malignancy Consortium

The Eighth Edition <scp>AJCC</scp> Cancer Staging Manual: Continuing to build a bridge from a population‐based to a more “personalized” approach to cancer staging

Mahul B. Amin, Frederick L. Greene, Stephen B. Edge et al. · CA A Cancer Journal for Clinicians · 2017 · 6.5K citations · Full text

Medicine, Cancer Biology, Oncology +17

Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular Carcinoma

Bo Hu, Xin‐Rong Yang, Yang Xu et al. · Clinical Cancer Research · 2014 · 2.3K citations · Full text

Medicine, Immunology, Oncology +15

Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study

Richard Fox, Daniel H. Palmer, Hassan Malik et al. · The Lancet Oncology · 2019 · 1.2K citations · Full text

Medicine, Oncology, Pharmacology +9

Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

Al B. Benson, Michael I. D’Angelica, Daniel E. Abbott et al. · Journal of the National Comprehensive Cancer Network · 2021 · 1K citations · Full text

Medicine, Oncology, Surgery +17

Lysis of tumor cells by natural killer cells in mice is impeded by platelets.

Bernhard Nieswandt, Michael Häfner, Bernd Echtenacher et al. · PubMed · 1999 · 838 citations

Life Sciences, Immunology, Oncology +13